Poland· PL-100069431
Uromitexan
A mesna product containing mesnum, registered in Poland by Baxter Polska Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Mesna is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AF01 (mesna), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Mesna · ATC V03AF01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Mesnum
- Manufacturer
- Baxter Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- V03AF01
- ATC class
- Mesna
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990265817
- gtin05909990265824
- gtin05909990265831
- gtin05909990265848
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mesna in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenUromitexan (med konserveringsmedel) 100 mg/ml Injektionsvätska, lösningBaxter Medical AB
- BelgiumUromitexan 400 mg/4 mlBaxter
- SwitzerlandUromitexan, Injektions-/InfusionslösungBaxter AG
- IcelandUromitexanBaxter Medical AB*
- NorwayUromitexanBaxter Medical AB
- United KingdomMesna 1g/10ml solution for injection ampoulesA A H Pharmaceuticals Ltd
- United StatesmesnaHikma Pharmaceuticals USA Inc.
- FinlandUromitexanOrifarm Oy
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Uromitexan
- Belgium · Uromitexan
- Bulgaria · Уромитексан
- Czechia · Uromitexan
- Germany · Mesna Cell, Mesna-Cell Stadapharm
- Denmark · Uromitexan, Uromitexan Cum Conservans
- Estonia · Uromitexan
- Spain · Mesna Altan, Mucofluid
- Finland · Uromitexan, Uromitexan Cum Conservans
- France · Mesna Eg, Uromitexan
- United Kingdom (Northern Ireland) · Mesna Baxter Healthcare
- Greece · Uromitexan
- Croatia · Uromitexan
- Hungary · Uromitexan
- Ireland · Uromitexan
- Iceland · Uromitexan
- Italy · Uromitexan
- Lithuania · Uromitexan
- Luxembourg · Uromitexan
- Latvia · Uromitexan
- Malta · Uromitexan
- Netherlands · Uromitexan
- Norway · Uromitexan
- Portugal · Uromitexan
- Romania · Uromitexan
- Sweden · Uromitexan, Uromitexan (Med Konserveringsmedel)
- Slovakia · Uromitexan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0abc5338-80e1-4821-81e7-b1395a649df8 GET /v1/drugs/0abc5338-80e1-4821-81e7-b1395a649df8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "100 mg/ml",
"packaging": "Rp ¦ Skasowane ¦ 10416\n15 amp. 1 ml\nRp ¦ Skasowane ¦ 10417\n30 amp. 1 ml\n05909990265817 ¦ Rp ¦ Skasowane ¦ 14427\n15 amp. 2 ml\n05909990265824 ¦ Rp ¦ Skasowane ¦ 14428\n30 amp. 2 ml\n05909990265831 ¦ Rp ¦ 14429\n15 amp. 4 ml\n05909990265848 ¦ Rp ¦ 14430\n30 amp. 4 ml",
"substance": "Mesnum 100 mg",
"common_name": "Mesnum",
"pl_product_id": "100069431",
"pozwolenie_nr": "02658",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about mesna.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.